Publications by authors named "Katja Thomas"

Claim this Profile
N
Natalizumab during pregnancy and lactation.
Undine Proschmann, Katja Thomas, Sandra Thiel, Kerstin Hellwig, Tjalf Ziemssen

Mult Scler· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?
Francisco Alejandro Rodriguez-Leal, Rocco Haase, Katja Thomas, Judith Christina Eisele, Undine Proschmann

Mult Scler· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".
Tony Sehr, Undine Proschmann, Katja Thomas, Tjalf Ziemssen

Mult Scler· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis.
Katja Thomas, Undine Proschmann, Tjalf Ziemssen

Expert Opin Pharmacother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world.
Tjalf Ziemssen, Katja Thomas

Ther Adv Neurol Disord· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: S. Sega-Jazbec et al.: "Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis" Multiple Sclerosis and Related Disorders 2017.
Katja Thomas, Tjalf Ziemssen

Mult Scler Relat Disord· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.
Tjalf Ziemssen, Hayrettin Tumani, Tony Sehr, Katja Thomas, Friedemann Paul

J Neuroinflammation· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment optimization in multiple sclerosis: how do we apply emerging evidence?
Tjalf Ziemssen, Katja Thomas

Expert Rev Clin Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation.
Katja Thomas, Tony Sehr, Undine Proschmann, Francisco Alejandro Rodriguez-Leal, Rocco Haase

J Neuroinflammation· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach.
Tjalf Ziemssen, Raimar Kern, Katja Thomas

BMC Neurol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Tjalf Ziemssen, Ulrich Engelmann, Sigbert Jahn, Alexandra Leptich, Raimar Kern, Katja Thomas

BMC Neurol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laquinimod in the treatment of relapsing remitting multiple sclerosis.
Undine Hainke, Katja Thomas, Tjalf Ziemssen

Expert Opin Drug Metab Toxicol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.
Katja Thomas, Judith Eisele, Francisco Alejandro Rodriguez-Leal, Undine Hainke, Tjalf Ziemssen

Neurol Neuroimmunol Neuroinflamm· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.
Raimar Kern, Rocco Haase, Judith Christina Eisele, Katja Thomas, Tjalf Ziemssen

Interact J Med Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Katja Thomas, Kristin Dietze, Rebekka Wehner, Imke Metz, Hayrettin Tumani

Neurol Neuroimmunol Neuroinflamm· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Katja Thomas, Hagen Schrötter, Michael Halank, Tjalf Ziemssen

BMC Neurol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of fingolimod in clinical practice.
Katja Thomas, Tjalf Ziemssen

Clin Neurol Neurosurg· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.
Simone Kern, Ivonne Krause, Antje Horntrich, Katja Thomas, Julia Aderhold

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.
Tjalf Ziemssen, Raimar Kempcke, Marco Eulitz, Lars Großmann, Alexander Suhrbier, Katja Thomas

J Neural Transm (Vienna)· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Katja Thomas, Thorsten Schultheiss, Tjalf Ziemssen

Neurology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern communication technology skills of patients with multiple sclerosis.
Rocco Haase, Thorsten Schultheiss, Raimar Kempcke, Katja Thomas, Tjalf Ziemssen

Mult Scler· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Rocco Haase, Thorsten Schultheiss, Raimar Kempcke, Katja Thomas, Tjalf Ziemssen

J Med Internet Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The parasite fauna of stray domestic cats (Felis catus) in Dubai, United Arab Emirates.
Rolf K Schuster, Katja Thomas, Saritha Sivakumar, Declan O'Donovan

Parasitol Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis